A team of clinician-scientists and scientists, led by the National Cancer Centre Singapore and A*STAR’s Genome Institute of Singapore together with collaborators in Europe and South Korea, used single-cell techniques to uncover a central dichotomy for colorectal cancer cells, leading to a proposed update of the classification system for the disease.
Tumor malignancy identification plays an essential role in clinical management of cancer. Currently, biopsy is the gold standard for malignancy identification in most tumor cases, it is, however, invasive that can cause great discomfort to patients, and potentially increase the risk of distant metastases due to the complex sampling process.
Research from a new study suggests that health anxiety among the clinically vulnerable groups who shielded at home has risen since the first pandemic wave, despite developments in viral treatment and the roll-out of the vaccination programme.
As a child growing up in San Jose, California, Marta Segura heard horrific stories from her parents about women fainting on the factory lines and men overheating in the farm fields.
A new study has reported two renal transplant cases, in which individuals, after being exposed to remdesivir, developed a resistance to the drug.
Lori Mangum was 32 when apple-size tumors sprouted on her head. Now — six years and 10 surgeries later — the skin cancer is gone. But her pain lives on, in the form of medical debt.
In response to the Supreme Court’s overturning of Americans’ constitutional right to abortion, large employers thought they had found a way to help workers living in states where abortions would be banned: provide benefits to support travel to other states for services. But that solution is only triggering questions.
Consumers, employers, and just about everyone else interested in health care prices will soon get an unprecedented look at what insurers pay for care, perhaps helping answer a question that has long dogged those who buy insurance: Are we getting the best deal we can?
Researchers developed a new detection assay for SARS-CoV-2.
Researchers assessed the impact of pre-existing immunity on mRNA booster doses of BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2.